Transverse expansion in sup 1 sup 9 sup 7 Au + sup 1 sup 9 sup 7 Au collisions at RHIC

por Cheng, Y, Liu, F, Liu, K, Schweda, K, Xu, N
Publicado 2003

Proteomics progresses in microbial physiology and clinical antimicrobial therapy

por Chen, B., Zhang, D., Wang, X., Ma, W., Deng, S., Zhang, P., Zhu, H., Xu, N., Liang, S.
Publicado 2016

Organic zinc supplementation in early-lactation dairy cows and its effects on zinc content and distribution in milk and cheese

por Xu, N.N., Yang, D.T., Miao, C., Valencak, T.G., Liu, J.X., Ren, D.X.
Publicado 2021

Erratum to “Organic zinc supplementation in early-lactation dairy cows and its effects on zinc content and distribution in milk and cheese” (JDS Commun. 2:110–113)

por Xu, N.N., Yang, D.T., Miao, C., Valencak, T.G., Liu, J.X., Ren, D.X.
Publicado 2022

Development of a lytic peptide derived from BH3-only proteins

por Liu, Q, Zhao, H, Jiang, Y, Wu, M, Tian, Y, Wang, D, Lao, Y, Xu, N, Li, Z
Publicado 2016

Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours

por Wang, Y, Hewitt, S M, Liu, S, Zhou, X, Zhu, H, Zhou, C, Zhang, G, Quan, L, Bai, J, Xu, N
Publicado 2006

Diffuse interstitial and multiple cavitary lung lesions due to Talaromyces marneffei infection in a non-HIV patient

por Li, H.R., Xu, N.L., Lin, M., Hu, X.L., Chen, J.H., Chen, Y.S., Cai, S.X.
Publicado 2015

The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors

por Zhou, W-J, Xu, N, Kong, L, Sun, S-C, Xu, X-F, Jia, M-Z, Wang, Y, Chen, Z-Y
Publicado 2016

NP30 stimulates Th17 differentiation through DC in Schistosomiasis Japonicum

por Xu, L., Xue, B., Zhou, L., Qiu, Z., Zhang, X., Xu, N., Tang, Q., Zhu, J., Guan, X., Feng, Z.
Publicado 2018

High-temperature superconductivity from fine-tuning of Fermi-surface singularities in iron oxypnictides

por Charnukha, A., Evtushinsky, D. V., Matt, C. E., Xu, N., Shi, M., Büchner, B., Zhigadlo, N. D., Batlogg, B., Borisenko, S. V.
Publicado 2015

Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation tri...

por Mao, C., Ji, D., Ding, Y., Zhang, Y., Song, W., Liu, L., Wu, Y., Song, L., Feng, X., Zhang, J., Cao, J., Xu, N.
Publicado 2023

Site-specific therapy in cancers of unknown primary site: a systematic review and meta-analysis

por Ding, Y., Jiang, J., Xu, J., Chen, Y., Zheng, Y., Jiang, W., Mao, C., Jiang, H., Bao, X., Shen, Y., Li, X., Teng, L., Xu, N.
Publicado 2022

MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability

por Liu, L, He, J, Wei, X, Wan, G, Lao, Y, Xu, W, Li, Z, Hu, H, Hu, Z, Luo, X, Wu, J, Xie, W, Zhang, Y, Xu, N
Publicado 2017

Characterization of carbapenem‐resistant Klebsiella pneumoniae in a tertiary hospital in Fuzhou, China

por Chen, D., Li, H., Zhao, Y., Qiu, Y., Xiao, L., He, H., Zheng, D., Li, X., Huang, L., Yu, X., Xu, N., Hu, X., Chen, Y., Chen, F.
Publicado 2020

Micro-metric electronic patterning of a topological band structure using a photon beam

por Frantzeskakis, E., De Jong, N., Zwartsenberg, B., Huang, Y. K., Bay, T. V., Pronk, P., Van Heumen, E., Wu, D., Pan, Y., Radovic, M., Plumb, N. C., Xu, N., Shi, M., De Visser, A., Golden, M. S.
Publicado 2015

First-in-human, phase I study of AK109, an anti-VEGFR2 antibody in patients with advanced or metastatic solid tumors

por Zheng, Y., Zhong, H., Zhao, F., Zhou, H., Mao, C., Lv, W., Yuan, M., Qian, J., Jiang, H., Wang, Z., Xiao, C., Guo, J., Liu, T., Liu, W., Wang, Z.M., Li, B., Xia, M., Xu, N.
Publicado 2023

MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma

por Sonkoly, E, Lovén, J, Xu, N, Meisgen, F, Wei, T, Brodin, P, Jaks, V, Kasper, M, Shimokawa, T, Harada, M, Heilborn, J, Hedblad, M-A, Hippe, A, Grandér, D, Homey, B, Zaphiropoulos, P G, Arsenian-Henriksson, M, Ståhle, M, Pivarcsi, A
Publicado 2012

Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies

por Li, J., Cheng, Y., Bai, C., Xu, J., Shen, L., Li, J., Zhou, Z., Li, Z., Chi, Y., Yu, X., Li, E., Xu, N., Liu, T., Lou, W., Bai, Y., Yuan, X., Wang, X., Yuan, Y., Chen, J., Guan, S., Fan, S., Su, W.
Publicado 2022

Observation of Weyl nodes and Fermi arcs in tantalum phosphide

por Xu, N., Weng, H. M., Lv, B. Q., Matt, C. E., Park, J., Bisti, F., Strocov, V. N., Gawryluk, D., Pomjakushina, E., Conder, K., Plumb, N. C., Radovic, M., Autès, G., Yazyev, O. V., Fang, Z., Dai, X., Qian, T., Mesot, J., Ding, H., Shi, M.
Publicado 2016

P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA...

por Xu, Z., Duan, M., Jiang, Q., Leng, Q., Xu, N., Zhang, Y., Zhao, C., Wu, W., Zhang, Q., Fu, J., Zhang, J., Fu, R., Yan, Z., Zhang, J., Lin, C., Ouyang, G., Wang, Z., Ma, L., Hao, H., Li, X., Ran, S., Chen, Y., Li, T., Xiao, Z.
Publicado 2022